Daniel Thiel, an associate in the Antitrust group, has broad litigation experience, including representing clients in toxic tort, telecommunications, product liability, and trade secret matters.
Since joining the firm in 2014, Daniel’s primary focus has been representing plaintiff retail pharmacies in “reverse payment” litigation, a burgeoning area involving the intersection of patent and antitrust law. He has also represented clients in bringing Sherman Act conspiracy claims against major chocolate manufacturers, as well as the nation’s largest mushroom farmer cooperative. Daniel has represented clients in antitrust actions in federal courts across the United States, including matters in California, Georgia, Massachusetts, New York, and Tennessee. He earned his law degree from the University of Pennsylvania Law School, where he was Associate Editor of the Journal of Constitutional Law and earned Honors in Legal Research and Writing. He earned his undergraduate degree, summa cum laude, from Villanova University.
In re AndroGel Antitrust Litigation II, 09-MD-2084-TWT (N.D. Ga.): Currently representing retail pharmacies against brand and generic pharmaceutical manufacturers in “pay for delay” litigation.
In re Lidoderm Antitrust Litigation, 14-MD-02521-WHO (N.D. Cal.): Currently representing retail pharmacies against brand and generic pharmaceutical manufacturers in litigation involving a “no authorized generic” agreement.
In re Mushroom Direct Purchaser Antitrust Litigation, No. Civ. 06-0620 (E.D. Pa.): Currently serving as class counsel in Sherman Act section 1 litigation against the nation’s largest mushroom farmer cooperative.